Plain-English translation of NCT06191302 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that follows people who were hospitalized with COVID-19 to understand what happens to their health months after the acute infection ends. Researchers will collect blood samples and review medical records to look for signs of long-term damage to the lungs, heart, and kidneys, and to identify blood markers that might predict these complications before they develop.
Many people who recover from COVID-19 hospitalization develop ongoing health problems in their lungs, heart, or kidneys. Doctors don't yet understand why this happens or how to predict who will be affected, so this study aims to find biological clues that could help identify at-risk patients early and prevent these complications.
You likely qualify if…
You likely don't qualify if…
If you participate, you will donate a blood sample (if you haven't already) and allow researchers to access your medical records and hospital data related to your COVID-19 hospitalization and your health afterward. The study will also compare your health outcomes to a control group of people who were hospitalized with other respiratory illnesses. Follow-up may involve additional health questionnaires or monitoring over time as part of the research.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Denmark